Armeen Mahvash

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

Van K. Morris, Mohamed E. Salem, Halla Nimeiri et al. · The Lancet Oncology · 2017 · 393 citations

Medicine, Oncology, Pharmacotherapy +12

Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant

Junichi Shindoh, Mark J. Truty, Thomas A. Aloia et al. · Journal of the American College of Surgeons · 2012 · 332 citations

Medicine, Oncology, Surgery +17

Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Approach

Junichi Shindoh, Jean‐Nicolas Vauthey, Giuseppe Zimmitti et al. · Journal of the American College of Surgeons · 2013 · 254 citations · Full text

Medicine, Oncology, Surgery +10

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

Hugo Levillain, Oreste Bagni, Christophe M. Deroose et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 245 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Yan Xing, Nancy U. Lin, Matthew Maurer et al. · Breast Cancer Research · 2019 · 227 citations · Full text

Medicine, Oncology, Pharmacotherapy +17